Oximes

acetylcholinesterase (Cartwright blood group) ; Homo sapiens







304 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33563155 Synthesis, Molecular Docking, BSA, and In Vitro Reactivation Study of Imidazopyridine Oximes Against Paraoxon Inhibited Acetylcholinesterase. 2022 1
2 34558680 Caged Oxime Reactivators Designed for the Light Control of Acetylcholinesterase Reactivation. 2022 Mar 3
3 35164361 Discovery of Novel Non-Oxime Reactivators Showing In Vivo Antidotal Efficiency for Sarin Poisoned Mice. 2022 Feb 7 1
4 35489467 Theoretical assessment of the performances of commercial oximes on the reactivation of acetylcholinesterase inhibited by the nerve agent A-242 (novichok). 2022 Jul 1
5 35526478 Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents. 2022 Aug 5 5
6 35527825 Use of connectivity index and simple topological parameters for estimating the inhibition potency of acetylcholinesterase. 2022 Apr 1
7 32334495 Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds. 2021 1
8 33588047 Development of a simple QSAR model for reliable evaluation of acetylcholinesterase inhibitor potency. 2021 May 1 2
9 33592259 Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes. 2021 Mar 30 1
10 33990679 Non-quaternary oximes detoxify nerve agents and reactivate nerve agent-inhibited human butyrylcholinesterase. 2021 May 14 1
11 34019427 Effect of Oxime Encapsulation on Acetylcholinesterase Reactivation: Pharmacokinetic Study of the Asoxime-Cucurbit[7]uril Complex in Mice Using Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry. 2021 Jun 7 2
12 34324828 Covalent inhibition of hAChE by organophosphates causes homodimer dissociation through long-range allosteric effects. 2021 Sep 2
13 34330964 Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach. 2021 Jul 30 2
14 34541552 Room temperature crystallography of human acetylcholinesterase bound to a substrate analogue 4K-TMA: Towards a neutron structure. 2021 2
15 34671741 Dual acting oximes designed for therapeutic decontamination of reactive organophosphates via catalytic inactivation and acetylcholinesterase reactivation. 2021 Sep 23 2
16 31022458 Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures. 2020 Jan 2
17 31830555 Assessment of false transmitters as treatments for nerve agent poisoning. 2020 Mar 15 1
18 32019865 Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase. 2020 Mar 27 2
19 32086265 Early diagnosis of nerve agent exposure with a mobile test kit and implications for medical countermeasures: a trigger to react. 2020 Apr 1
20 32105443 Pharmacokinetic Evaluation of Brain Penetrating Morpholine-3-hydroxy-2-pyridine Oxime as an Antidote for Nerve Agent Poisoning. 2020 Apr 1 1
21 32175496 Molecular Modeling Study of Uncharged Oximes Compared to HI-6 and 2-PAM Inside Human AChE Sarin and VX Conjugates. 2020 Mar 10 6
22 32178264 Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016-2019). 2020 Mar 12 1
23 32267631 A novel high-performance liquid chromatography with diode array detector method for the simultaneous quantification of the enzyme-reactivating oximes obidoxime, pralidoxime, and HI-6 in human plasma. 2020 Jul 2
24 32333945 Efficient detoxification of nerve agents by oxime-assisted reactivation of acetylcholinesterase mutants. 2020 Jul 2
25 32380126 In vitro evaluation of two different types of obidoxime-loaded nanoparticles for cytotoxicity and blood-brain barrier transport. 2020 May 5 1
26 32388435 Design, synthesis and evaluation of novel nonquaternary and 3 non-oxime reactivators for acetylcholinesterase inhibited by organophosphates. 2020 Jul 3
27 32454005 Synthesis and in vitro evaluation of novel non-oximes for the reactivation of nerve agent inhibited human acetylcholinesterase. 2020 Aug 1 2
28 32544483 Oxime-mediated reactivation of organophosphate-inhibited acetylcholinesterase with emphasis on centrally-active oximes. 2020 Sep 15 2
29 32835730 Effect of P-glycoprotein on the availability of oxime reactivators in the brain. 2020 Oct 1
30 32899591 Understanding the Interaction Modes and Reactivity of Trimedoxime toward MmAChE Inhibited by Nerve Agents: Theoretical and Experimental Aspects. 2020 Sep 5 1
31 30444932 Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase. 2019 Apr 11 2
32 30458057 Reversal of Tabun Toxicity Enabled by a Triazole-Annulated Oxime Library-Reactivators of Acetylcholinesterase. 2019 Mar 15 4
33 30682493 Oxidative stress induced by oxime reactivators of acetylcholinesterase in vitro. 2019 Apr 1
34 30858091 The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM). 2019 Jun 15 1
35 30950246 Prediction of Ligands Binding Acetylcholinesterase with Potential Antidotal Activity: A Virtual Screening Approach. 2019 Jun 1
36 30978400 Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase. 2019 Jun 1 3
37 31074292 Molecular modeling studies on the interactions of 7-methoxytacrine-4-pyridinealdoxime, 4-PA, 2-PAM, and obidoxime with VX-inhibited human acetylcholinesterase: a near attack conformation approach. 2019 Dec 1
38 31112674 Current approaches to enhancing oxime reactivator delivery into the brain. 2019 Jul 1 3
39 31138650 Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase. 2019 Jul 5 3
40 31176713 A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies. 2019 Aug 25 2
41 31276662 Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro models. 2019 Sep 1 2
42 28446076 Behavior of uncharged oximes compared to HI6 and 2-PAM in the human AChE-tabun conjugate: a molecular modeling approach. 2018 May 2
43 28722512 In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication. 2018 Jan 3
44 28993240 The oximes HI-6 and MMB-4 fail to reactivate soman-inhibited human and guinea pig AChE: A kinetic in vitro study. 2018 Sep 1 3
45 29180286 The estimation of oxime efficiency is affected by the experimental design of phosphylated acetylcholinesterase reactivation. 2018 Sep 1 2
46 29553731 Dynamic Mechanism of a Fluorinated Oxime Reactivator Unbinding from AChE Gorge in Polarizable Water. 2018 Apr 12 1
47 29577198 Study of the Oxime-induced Reactivation of Acetyl- and Butyrylcholinesterase of Human with Inhibition of Organophosphorus Insecticide In Vitro. 2018 Mar 1
48 29614332 New therapeutic approaches and novel alternatives for organophosphate toxicity. 2018 Jul 1
49 29735900 Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon. 2018 May 7 2
50 29772260 Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. 2018 Aug 1 3